Cargando…
A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas
Central nervous system tumors are classified based on an integrated diagnosis combining histology and molecular characteristics, including IDH1/2 and H3‐K27M mutations, as well as 1p/19q codeletion. Here, we aimed to develop and assess the feasibility of a glioma‐tailored 48‐gene next‐generation seq...
Autores principales: | Higa, Nayuta, Akahane, Toshiaki, Yokoyama, Seiya, Yonezawa, Hajime, Uchida, Hiroyuki, Takajo, Tomoko, Kirishima, Mari, Hamada, Taiji, Matsuo, Kei, Fujio, Shingo, Hanada, Tomoko, Hosoyama, Hiroshi, Yonenaga, Masanori, Sakamoto, Akihisa, Hiraki, Tsubasa, Tanimoto, Akihide, Yoshimoto, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541004/ https://www.ncbi.nlm.nih.gov/pubmed/32748499 http://dx.doi.org/10.1111/cas.14597 |
Ejemplares similares
-
Distribution and favorable prognostic implication of genomic
EGFR
alterations in
IDH
‐wildtype glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022) -
Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022) -
MPC-18 CATEGORIZATION OF LOWER GRADE GLIOMA USING ONCOPANEL
por: Uchida, Hiroyuki, et al.
Publicado: (2019) -
Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastoma
por: Makino, Ryutaro, et al.
Publicado: (2023) -
An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors
por: Hamada, Taiji, et al.
Publicado: (2022)